Calithera Biosciences, Inc. ( CALA) - Stock Earnings
CALA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 18, 2026, midnight | — / — | — | — / — | — |
CALA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | 10.2 million USD | 0 USD |
| 2022Q3 | -10.1 million USD | 0 USD |
| 2022Q4 | 14.1 million USD | — USD |
CALA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -88.5 million USD | 0 USD |
| 2021 | -165.3 million USD | 9.8 million USD |
| 2022 | -18.9 million USD | — USD |
| 2026 Est. | — | — |
CALA
Price: $0
52 week price:
Earnings Per Share: -2.65 USD
P/E Ratio: -3.31
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 883600
Ebitda: -6.6 millionMarket Capitalization: 1949